Aclarion, Inc. Common Stock (ACON) is a publicly traded Healthcare sector company. As of May 21, 2026, ACON trades at $3.14 with a market cap of $7.88M and a P/E ratio of -0.36. ACON moved +2.19% today. Year to date, ACON is -38.42%; over the trailing twelve months it is -54.10%. Its 52-week range spans $2.34 to $3,499.51. Analyst consensus is buy with an average price target of $7.00. Rallies surfaces ACON's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
ACON financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ACON recently traded at $3.14. Market cap is $7.88M. P/E ratio is -0.36. Revenue is $77.88K.
| Metric | Value |
|---|---|
| Price | $3.14 |
| Market Cap | $7.88M |
| P/E Ratio | -0.36 |
| EPS | $-9.03 |
| Dividend Yield | 0.00% |
| 52-Week High | $3,499.51 |
| 52-Week Low | $2.34 |
| Volume | 15 |
| Avg Volume | 0 |
| Revenue (TTM) | $77.88K |
| Net Income | $-8.05M |
| Gross Margin | 19.35% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $75.73K | $-7.24M | $-13.61 |
| 2024 | $45.72K | $-6.99M | $-7,480.00 |
| 2023 | $75.40K | $-4.91M | $-8.82 |
| 2022 | $60.44K | $-7.61M | $-1.31 |
1 analysts cover ACON: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $7.00.